Activity of ankylosing spondylitis in women within one year after childbirth
- Authors: Krichevskaya O.A.1, Dubinina T.V.1, Ilinykh E.V.1, Glukhova S.I.1, Demina A.B.1, Andrianova I.A.1
-
Affiliations:
- Nasonova Research Institute of Rheumatology
- Issue: Vol 94, No 5 (2022)
- Pages: 647-653
- Section: Original articles
- URL: https://journals.rcsi.science/0040-3660/article/view/108782
- DOI: https://doi.org/10.26442/00403660.2022.05.201497
- ID: 108782
Cite item
Full Text
Abstract
Aim. To assess the dynamics of activity of ankylosing spondylitis (AS) during the year after childbirth, to identify predictors of high activity.
Materials and methods. 75 pregnant with confirmed AS (modified New York criteria, 1984) were included for prospective observation. Of these, 44 women were followed up for 1 year after delivery. The average age of the patients was 32.5±5.8 years, the duration of the disease was 149.0±96.3 months. Lactation was established in 40 women and the duration was 10 [4; 12] months.
Results. The BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) at 1, 6 and 12 months after giving birth was 2.4 [1.4; 4.2], 2.6 [1.4; 4.4] and 2.7 [1.5; 4.1], respectively (p>0.05). ASDAS-CRP (Ankylosing Spondylitis Disease Activity Score – C-reactive protein) was 2.0 [1.2; 2.7], 1.9 [1.4; 2.5] and 1.7 [1.3; 2.3], respectively (p>0.05). There were no differences between the values of BASDAI, ASDAS-CRP between women with and without lactation. Predictors of high AS activity (BASDAI≥4) 1 month after delivery were: BASDAI≥4 in the 1st (odds ratio – OR 8.1; 95% confidence interval – CI 1,8–37,0) and 2nd trimesters of pregnancy (OR 5.1, 95% CI 1.2–20.6); NRS back pain >4 in the 2nd trimester (OR 4.3, 95% CI 1.1–17.2); cancellation of biological disease-modifying antirheumatic drugs therapy in the 1st trimester of pregnancy (OR 21.0, 95% CI 1.0–440.9). Predictors of high AS activity in 6 months after delivery were: BASDAI≥4 in the 1st (OR 6.5, 95% CI 1.5–28.7), in the 2nd (OR 6.7, 95% CI 1.6–27.8) and in the 3rd trimesters of pregnancy (OR 8.7, 95% CI 1.9–38.6); high activity in 1 month after delivery (OR 4.0, 95% CI 1.0–15.9).
Conclusion. AS activity remains stable for 1 year after delivery. High AS activity during pregnancy was a risk factor for high activity within 6 months after delivery.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Olga A. Krichevskaya
Nasonova Research Institute of Rheumatology
Author for correspondence.
Email: o.krichevskaya@mail.ru
ORCID iD: 0000-0002-1109-9865
канд. мед. наук, науч. сотр. лаб. аксиального спондилоартрита
Russian Federation, MoscowTatyana V. Dubinina
Nasonova Research Institute of Rheumatology
Email: o.krichevskaya@mail.ru
ORCID iD: 0000-0002-1771-6246
канд. мед. наук, зав. лаб. аксиального спондилоартрита
Russian Federation, MoscowEkaterina V. Ilinykh
Nasonova Research Institute of Rheumatology
Email: o.krichevskaya@mail.ru
ORCID iD: 0000-0002-6354-7244
науч. сотр. лаб. аксиального спондилоартрита
Russian Federation, MoscowSvetlana I. Glukhova
Nasonova Research Institute of Rheumatology
Email: o.krichevskaya@mail.ru
ORCID iD: 0000-0002-8843-705X
ст. науч. сотр. лаб. аксиального спондилоартрита
Russian Federation, MoscowAnastasia B. Demina
Nasonova Research Institute of Rheumatology
Email: o.krichevskaya@mail.ru
ORCID iD: 0000-0002-3106-3296
канд. мед. наук, науч. сотр. лаб. аксиального спондилоартрита
Russian Federation, MoscowIrina A. Andrianova
Nasonova Research Institute of Rheumatology
Email: o.krichevskaya@mail.ru
ORCID iD: 0000-0003-0291-524X
науч. сотр. лаб. аксиального спондилоартрита
Russian Federation, MoscowReferences
- Andreoli L, García-Fernández A, Chiara Gerardi M, Tincani A. The Course of Rheumatic Diseases During Pregnancy. Isr Med Assoc J. 2019;21(7):464-70.
- Mouyis M. Postnatal Care of Woman with Rheumatic Diseases. Adv Ther. 2020;37(9):3723-31. doi: 10.1007/s12325-020-01448-1
- Lui NL, Haroon N, Carty A, et al. Effect of Pregnancy on Ankylosing Spondylitis: A Case-Control Study. J Rheumatol. 2011;38(11):2442-4. doi: 10.3899/jrheum.101174
- Ursin K, Lydersen S, Skomsvoll JF, Wallenius M. Disease activity during and after pregnancy in women with axial spondyloarthritis: a prospective multicentre study. Rheumatology (Oxford). 2018;57(6):1064-71. doi: 10.1093/rheumatology/key047
- Jethwa H, Lam S, Smith C, Giles I. Does Inflammatory Arthritis Really Improve during Pregnancy? A Systematic Review and Meta-Analysis. Arthritis Rheumatol. 2019;46(3):245-50. doi: 10.3899/jrheum.180226
- Sieper J, Rudwaleit M, Baraliakos X, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68(Suppl. 2):ii1-44. doi: 10.1136/ard.2008.104018
- Dougados M, Simon P, Braun J, et al. ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis. Ann Rheum Dis. 2011;70(2):249-51. doi: 10.1136/ard.2010.133488
- Кричевская О.А., Гандалоева З.М., Глухова С.И., и др. Оценка активности анкилозирующего спондилита во время беременности с использованием различных индексов. Научно-практическая ревматология. 2020;58(5):503-11 [Krichevskaya OA, Gandaloeva ZM, Glukhova SI, et al. Assessment of Ankylosing Spondylitis Activity During Pregnancy Using Different Disease Activity Indices. Rheumatology Science and Practice. 2020;58(5):503-11 (in Russian)]. doi: 10.47360/1995-4484-2020-503-511
- Maguire S, O’Dwyer T, Mockler D, et al. Pregnansy in axial spondyloarthropaty: A systematic review & Meta-Analysis. Semin Arthritis Rheum. 2020;50(6):1269-79. doi: 10.1016/j.semarthrit.2020.08.011
- Ostensen M, Romberg O, Husby G. Ankylosing spondylitis and motherhood. Arthritis Rheum. 1982;25(2):140-3. doi: 10.1002/art.1780250204
- Ostensen M, Ostensen H. Ankylosing spondylitis – the female aspect. J Rheumatol. 1998;25(1):120-4.
- van den Brandt S, Zbinden A, Baeten D, et al. Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients. Arthritis Res Ther. 2017;19(1):64. doi: 10.1186/s13075-017-1269-1
- Genest G, Spitzer KA, Laskin CA. Maternal and Fetal Outcomes in a Cohort of Patients Exposed to Tumor Necrosis Factor Inhibitors throughout Pregnancy. J Rheumatol. 2018;45(8):1109-15. doi: 10.3899/jrheum.171152
- Timur H, Tokmak A, Turkmen GG, et al. Pregnancy outcome in patients with ankylosing spondylitis. J Matern Fetal Neonatal Med. 2016;29(15):2470-4. doi: 10.3109/14767058.2015.1089432
- Ikram N, Eudy A, Clowse MEB. Breastfeeding in women with rheumatic diseases. Lupus Sci Med. 2021;8:e000491. doi: 10.1136/lupus-2021-000491